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Abstract 
Trophoblast invasion is a key process during human placentation. This event constitutes the basis of the 
conversion of the uterine spiral arteries, a process which allows an adequate vascular connection between the 
intervillous space and the maternal blood flow. Trophoblast invasion is transient, with stringent spatial and 
temporal control. Preeclampsia, a leading cause of maternal and fetal mortality and morbidity, is associated with 
decreased, shallow trophoblastic invasion. In this article, we review the molecular mechanisms of trophoblast 




Implantation of the human egg occurs 6-7 days after conception. This process probably includes three stages. 
Apposition, the initial adhesion of the blastocyst to the uterine wall, usually occurs at the upper posterior wall of 
the uterus. Then stable adhesion of the blastocyst to the endometrium occurs. This event is followed by invasion 
of the decidua. At this moment, the embryonic pole of the blastocyst is oriented towards the uterine epithelium 
[1]. 
Trophoblast cells are derived from the trophoectoderm of the blastocyst. These cells adhere to the endometrium 
and initiate the process of implantation. During the first trimester of gestation, cytotrophoblast (CTB) stem cells 
reside in two types of chorionic villi, namely floating and anchoring villi. The CTBs can differentiate according 
to two distinct pathways, giving rise to two trophoblast populations that are morphologically and functionally 
distinct [2-5]. 
Fig. 1: Placental bed of a normal human pregnancy, 13 weeks of gestation. Intermediate trophoblasts 
(immunostained for cytokeratin, brown color, upper right part of the picture) invade the decidua close to a 
maternal artery (A). 
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Floating villi do not contact the uterine wall. In these villi, CTBs consist of a polarized epithelial monolayer, 
anchored to a basement membrane and surrounding a stromal core containing fetal blood vessels. These CTBs 
highly proliferate during the first trimester of gestation and differentiate exclusively by forming a multinucleated 
syncytium called syncytiotrophoblast (STB) that covers the villi. Floating villi are bathed by maternal blood and 
perform gas and nutrient exchange functions for the developing embryo. STBs also produce placental hormones 
and growth factors. 
Anchoring villi contain CTB stem cells that enter both pathways of differentiation. In much of the anchoring 
villus, CTB fuse to form STB. At day 10, the blastocyst is completely embedded into the stroma of the uterus, 
and CTBs break through the syncytial layer and form multilayered columns of nonpolarized cells. Anchoring 
villi, via these columns, physically connect the embryo to the uterine wall and are the source of the most highly 
invasive CTBs, the intermediate trophoblasts [6-8], found in the pregnant endometrium (decidua) and the first 
third of the myometrium, collectively designated the placental bed (fig. 1). A subpopulation of the intermediate 
trophoblasts invades the uterine blood vessels (endovascular invasion; fig. 2), a process which establishes 
adequate perfusion of the placenta [9,10]. The endovascular trophoblasts migrate to the uterine spiral arteries, 
where they replace the endothelial cell lining and the muscular and elastic layer of these arteries. This process, 
named conversion, occurs during the first trimester of pregnancy, and leads to low-resistance, high-capacitance 
blood vessels that allow for adequate blood flow during the pregnancy. 
Fig. 2: Normal uteroplacental artery, 14 weeks of gestation. The arterial wall is invaded by trophoblastic cells 
(immunostained for cytokeratin) who replace the media and endothelium. 
 
The process of anchoring villus formation and related CTB invasion of the uterine wall is extremely active 
during the first trimester of gestation. The morphology of the placenta is quite similar at the first and second 
trimester. During the third trimester, cell columns are no longer visible. 
Many aspects of trophoblast invasion are thought to be similar to events that occur during tumor cell invasion, 
when an in situ lesion becomes an invasive carcinoma, i.e. when cells penetrate an epithelial basement 
membrane and invade the underlying stroma [11]. Like malignant tumor invasion of the host tissue, trophoblast 
invasion of the maternal uterus is a multistep process. It involves attachment of the trophoblastic cells to the 
extracellular matrix (ECM) components, degradation of the ECM and migration through the connective tissue 
defect [5]. However, unlike tumor invasion, trophoblast invasion of the decidua is precisely regulated, confined 
spatially to the uterus and temporally to early pregnancy. 
Dysregulation of trophoblast invasion is associated with various pathological problems. Indeed, excessive 
invasion can lead to placenta accreta, increta or percreta [12] that constitute leading causes of postpartal 
hemorrhage. 
Uncontrolled trophoblast invasion can also lead to choriocarcinoma with possible metastases [13]. 
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On the other hand, inadequate trophoblast invasion is associated with preeclampsia. This entity is characterized 
by maternal edema, pregnancy-induced hypertension and proteinuria, and, in severe cases, eclampsia and 
abruptio placenta. Preeclampsia is associated with significant maternal and fetal death [12]. It is caused by 
limited trophoblastic invasion and a failure to convert the spiral arteries. This leads to the conservation of the 
reactivity of the maternal arteries to vasoconstrictive agents, resulting in placental hypoxia. Another entity 
associated with placental abnormalities and reduction of trophoblast invasion is intrauterine growth retardation. 
In-depth understanding of the molecular mechanisms that underlie trophoblast invasion could help understand 
the etiopathogenesis of diseases like preeclampsia and intrauterine growth retardation. It could also constitute the 
basis for new innovative therapeutic strategies for these diseases. In this article, we review the molecular 
mechanisms of trophoblastic invasion. 
ADHESION MOLECULES 
Adhesion of various types of cells are mediated through specific cell surface receptors designated integrins. 
These receptors are heterodimeric αβ-type transmembrane glycoproteins. Their specificity of binding depends on 
the type of α/β combination. CTBs express integrins to adhere to ECM components, and modulate their integrin 
repertoire when they invade the mother tissues (table 1) [14, 15]. Examination of first trimester placenta [14, 16] 
and of an in vitro model of Matrigel invasion by CTBs [15] reveals that the invasion of CTBs leads to a 
decreased expression of adhesion receptors characteristic of CTB stem cells, and an increase in the expression of 
adhesion receptors that are characteristic of vascular cells. 
Indeed, villous CTBs predominantly express the α6β4 integrin, a laminin receptor. In contrast, the invasive 
extravillous CTBs present with a differentially modulated integrin repertoire. Columnar CTBs express α6β4 in a 
nonpolarized fashion; more distal, placental bed-invasive CTBs express α5β1 integrin, a fibronectin receptor. 
Interstitial and endovascular CTBs also express α1β1, a laminin and collagen receptor [14, 15]. This profile of 
integrin expression is also observed on CTBs that invade Matrigel [15]. The importance of these adhesion 
molecules has been highlighted by in vitro experiments. Antibody perturbation of the interactions involving 
α1β1, type IV collagen and laminin inhibits CTB invitro invasion, whereas perturbing interactions between 
fibronectin and α5β1 promoted invasion [15]. 
Table 1: Expression of adhesion molecules and integrins in first trimester trophoblast [data from 14, 17, 23-26, 
117] 
 Zone I Zone II Zone III Zone IV Zone V  












α1 - - - + + ± 
α4 - + + + + ± 
β1 ± ± + + + + 
β3 - - + + + + 
β4 + + ± - - - 
β5 + - - - - - 
β6 ± ± - - - - 
E-cadherin + + ± ± - - 
VE-cadherin - + + + + + 
αVβ3 - - - + + + 
VCAM-1 - ± + + + ± 
PECAM-1 - - + + + + 
NCAM-1 - - - - +  
CEACAM-1 - + ± ± ±  
MCAM - + + + +  
E-selectin + + + + + ± 
L-selectin + + + + +  
Zone I — Monolayer of CTB on the trophoblast basement membrane; zones II and II — cell aggregate (column) formed by differentiating 
CTB; zone IV = interstitial trophoblasts that have invaded the maternal decidua; zone V = endovascular trophoblasts and placental bed 
CTBs. 
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The CTBs also undergo an epithelial to endothelial cell transformation. Indeed, they decrease E-cadherin, and 
increase endothelial-specific adhesion molecules, such as VE-cadherin, PECAM-1 and VCAM-1 [17-20]. They 
also express various vasodilatory and anticoagulative factors [21]. Functional studies using blocking antibodies 
reveal that αVβ3 and VE-cadherin enhance, and E-cadherin decreases CTB invasion [17]. 
Examination of placenta from the second and third trimester of gestation revealed similar patterns of integrin 
expression with only slight differences [16]. Indeed, during the second trimester, the α3 integrin subunit is 
detected on villous CTBs, columns and placental bed CTBs. Third trimester floating villi are characterized by 
persisting expression of the α6 integrin subunit, whereas β4 is not detected. 
Fig. 3: Immunohistochemical localization of galectin-3 in a first trimester galectin-3 expression when polarized 
CTBs (arrows) differentiate to form the trophoblastic cell column (TCC). S = Villous stroma. 
 
The focal adhesion kinase (FAK), which is implicated in signal transduction after binding of the ligand on 
integrins, is expressed by CTBs in all stages of differentiation [22]. Autophosphorylation on tyrosine 397 
(Y397FAK) is only detected in a subset of invasive CTBs near the surface of the uterine wall. It appears to 
mediate CTB invasion, as antisense FAK induces a striking reduction of in vitro invasion [22]. 
Other adhesion molecules are differentially expressed during trophoblast differentiation and invasion. For 
instance, the adhesion molecule CEACAM-1 (CD66a) is not expressed in villous CTB and STB; it is strongly 
expressed in proximal columns, and is also observed in interstitial and endovascular trophoblasts [23, 24]. 
Human trophoblasts express functional L-selectin, a molecule that could play an important role during 
interactions between the trophoblasts and the uterine luminal epithelium [25]. Melanoma cell adhesion molecule 
(MCAM) is expressed by extravillous CTBs but not villous CTBs [26]. The expression of galectin-3, a 
mammalian lactose-binding lectin implicated during cancer progression [27], is downregulated during the first 
trimester of gestation, with minimal expression at 12 weeks when invasion is maximal [28]. 
Immunohistochemistry reveals that expression of galectin-3 is decreased when trophoblasts differentiate into cell 
columns [29], i.e. when CTBs acquire a migratory phenotype (fig. 3). 
Placentas from preeclamptic patients are characterized by defective trophoblastic invasion and by abnormal 
switching of integrins. Indeed, placental bed CTBs present with a persisting expression of α6β4 and absence of 
α1 upregulation, suggesting that α6β1 integrin is expressed by placental bed CTBs as early as the late second 
trimester, a situation that does not exist in normal pregnancy until term [16]. Levels of plasma membrane 
Y397FAK are also decreased [22]. Moreover, preeclamptic CTBs fail to mimic a vascular adhesion phenotype 
and retain expression of αVβ6 and E-cadherin, and fail to upregulate αVβ3, VE-cadherin, VCAM-1 and 
PECAM-1 [30]. In in vitro experiments, preeclamptic CTBs are also characterized by reduced invasion and α1 
integrin expression [31]. This suggests that preeclamptic trophoblasts present with an altered expression of 
adhesion molecules, resulting in a reduced ability to invade the decidua. 
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PROTEASES 
A large body of evidence demonstrates that trophoblast invasion is not due to passive mechanisms but is an 
active process. Indeed, trophoblasts from the first trimester of gestation are able to degrade the matrix by 
secreting proteases [5, 32-34]. Several types of proteases have been involved in this process, including serine 
proteases, cathepsins and matrix metalloproteinases. Secretion of these proteases begins already at the blastocyst 
stage [35, 36]. 
Human CTBs are able to invade amniotic membranes [37] and Matrigel invitro [38-40], and to digest ECM [5]. 
This behavior is clearly related to secreted metalloproteinases, as TIMP expression inhibits their invasiveness 
[37]. Gelatin zymography demonstrates that several metalloproteinases are uniquely expressed by first-trimester 
invasive CTBs, and not by second- and third-trimester trophoblasts [5]. Matrigel invasion by CTBs is clearly 
related to expression and activity of MMP-2 and MMP-9 (gelatinase B) [5, 41]. Expression and activation of 
MMP-9 peak during the first trimester of pregnancy at the moment when invasion is maximal [40-42]. 
Human extravillous CTBs acquire an invasive phenotype on Matrigel associated with a specific pattern of 
protease gene expression, including increased MMP-12, MT2-MMP, TIMP-2 and TIMP-3 expression, and 
decreased MMP-2 and TIMP-1 expression [43]. Increased expression of TIMP-3 by trophoblasts, simultaneous 
to that of MMP-9, provides a mechanism for controlling MMP-mediated invasion [44]. Trophoblast invasion 
seems also regulated by the production of MMPs and TIMPs by the maternal decidua [45]. Invasive trophoblasts 
produce stromelysin-3 during both, the first and third trimesters of pregnancy, but to a lesser extent during the 
latter [46]. STBs from the floating villi also express stromelysin-3 [46]. Plasminogen activator inhibitors or a 
function-perturbing antibody raised against uPA only partially inhibit CTB invasion in vitro [41]. Human 
trophoblast also expresses urokinase-type plasminogen activator receptor [47] that can bind active urokinase-
type PA and concentrate proteolysis at the invading edge of the cells. Activity of this system is altered in 
preeclampsia [48]. Proteolysis of the thrombin receptor, protease-activated receptor-1 (PAR-1), is the 
predominant thrombin receptor on invasive extravillous trophoblast cells and may play an important role during 
trophoblast invasion [49]. Cathepsin B and L may also be important during trophoblast invasion [50]. 
Examination of preeclamptic patients reveals that their trophoblasts are characterized by reduced in vitro 
invasion and MMP-9 expression [31] and activation [48], and secrete less cell surface PAI [48]. 
REGULATION OF TROPHOBLASTIC INVASION 
Trophoblastic invasion is controlled by several factors. The trophoblasts should first differentiate to anchoring 
trophoblasts. This is partly attributed to the contact of the trophoblast with specific, still to be characterized 
decidual factors, via either paracrine stimulation or direct contact with the decidual ECM [51]. This view is 
somewhat complicated by a recent study that examines viable tubal pregnancies [52], showing that extravillous 
trophoblast differentiation [defined by expression of different molecules including integrins, E-cadherin, EGF 
receptor (EGF-R), Ki-67 and HLA-G] was similar, except for the fact that the columns were markedly longer in 
tubal pregnancies [52]. 
Steroids 
Treatment of first trimester CTBs with progesterone decreases MMP-9 expression [53]. 
Extracellular Matrix 
Type I collagen has the ability to stimulate gelatinase secretion by CTBs [54]. 
Hormones and Cytokines 
Placental expression of chemokines is specific to either the stromal or CTB compartment of the villi [55], 
suggesting that they could participate in trophoblast differentiation and invasion. 
Transforming growth factor-β produced by the decidua [56, 57], STBs and extravillous CTBs [58] induces 
trophoblast differentiation toward an anchoring phenotype including production of oncofetal fibronectin [59, 60]. 
The EGF-R is mainly expressed by villous CTB and STB [61], and surrounding decidual cells [62]. This 
receptor can bind EGF (expressed in uterine epithelial and decidual cells, and villous CTBs and STBs [63]), 
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TGF-α (expressed in decidual cells and all trophoblast lineages [64]) and amphiregulin (expressed by STBs 
before 18 weeks of gestation [65]), and stimulate extravillous trophoblast proliferation [64, 66]. 
Production of LIF by postovulatory endometrium [67] could decrease trophoblast synthesis of human chorionic 
gonadotrophin (hCG), and increases oncofetal fibronectin, which suggests that it stimulates CTB differentiation 
towards an anchoring extravillous phenotype [68]. 
It has been shown that the hypoxia-inducible factor-1α (HIF-1α) increases the expression of several genes 
important for invasion. This includes TGF-β3, the expression profile of which is similar to that of HIF-lα [69, 
70]. This molecule is an inhibitor of the invasive extravillous phenotype of trophoblasts [70]. Preeclampsia is 
characterized by persistence of TGF-β3 expression after the first trimester and trophoblasts are arrested at an 
intermediate immature phenotype [69, 70], suggesting that this anomaly is linked to the defective trophoblast 
invasion characteristic of the disease. Interestingly, in vitro antisense inhibition of TGF-β3 expression or 
inhibition of TGF-β3 activity with blocking antibodies induces the formation of columns of CTBs and restores 
their in vitro invasive phenotype [69]. 
Numerous hormones and cytokines are also able to modulate trophoblast invasion by modulating the expression 
or activity of adhesion molecules or proteases. 
The cytokines IL-1 and IL-6 increase the expression of the α1 and α2 integrin subunits in CTBs [71]. Expression 
of integrin α1 and in vitro invasion of CTBs are reduced when interfering with the binding of VEGF ligands to 
the CTBs [72]. Leptin, IL-1α, IL-6 and TGF-β increase the expression of the α5 and α6 integrin subunits [73]. 
Insulin growth factor binding protein-1 (IGFBP-1), the major secretory product of the decidualized 
endometrium, binds the α5βl integrin and stimulates cell migration [74]. Both IGF-II, which is produced by 
extravillous CTBs and IGFBP-1, synergistically enhance invasion of first trimester trophoblast cells [75]. 
MCAM expression of MCAM in JEG3 cells and trophoblast expiants is increased in the presence of human 
decidual tissue through PKA and cAMP pathways [26]. 
In vitro invasion and collagenolytic activity of the cytotrophoblastic JEG-3 cells is stimulated by hCG through a 
cAMP-dependent pathway [76]. Human first trimester CTB in vitro invasion is upregulated by EGF [77] and 
hepatocyte growth factor (HGF) from the stroma of the villi [78]. Preeclampsia is characterized by a decreased 
expression of HGF by the stroma of the villi [78]. Protein kinase C activators such as phorbol esters increase in 
vitro trophoblast invasion [38] and secretion of MMP-9 [79]. The activity of MMP-9 is upregulated by leptin and 
IL-1α [73, 80], and it is known that IL-1 concentrations in embryo culture medium are correlated with success of 
in vitro fertilization procedures [81]. 
CSF-1 present at the fetomaternal interface [82, 83] binds to the M-CSF receptor (M-CSF-R, the product of c-
fms) present on trophoblast cells since the blastocyst stage, and, later, on extravillous CTBs [83-85]. It increases 
cell proliferation but not invasiveness, and increases expression of both MMP-2 and TIMP-1 [86]. The 
expression of M-CSF-R has been correlated with trophoblast invasiveness [62]. 
Immune System 
The placental bed contains a large population of immune cells, including uterine natural killer (NK) cells [87]. 
The survival of the conceptus depends on its acceptance, or nonrejection, by the maternal immune system [88]. 
Thus, the maternal immune system likely interacts with the process of trophoblast invasion. 
For instance, HLA-G, a major histocompatibility tissue-specific antigen of low polymorphism, is expressed by 
invasive extravillous CTBs, including interstitial trophoblasts, placental bed giant cells and endovascular 
trophoblasts [89]. HLA-G1 reduces both CD8+ and CD4+ T cell reactivity and decreases innate immunity of 
uterine NK cells [90, 91]. This could contribute to protecting invasive CTBs from attack by the uterine NK cells 
[92] and enables these cells to invade the uterus. In preeclampsia, expression of HLA-G is reduced or absent in 
extravillous CTBs [31, 93-95]. This could lead to a defective recognition of infiltrating CTBs by uterine NK 
cells, resulting in defective invasion and spiral artery conversion [96, 97]. 
A recent study demonstrates a specific profile of chemokine expression in the stromal compartment and 
trophoblast population of the chorionic villi, which could participate, for instance, in the recruitment of the 
resident macrophage (Hofbauer cell) population of the villi, CTB differentiation and invasion [55]. 
Published in : Chemical Immunology and Allergy (2005), vol. 88, pp 163-80 
Status : Postprint (Author’s version) 
 
Transcription Factors 
It seems that the invasive phenotype of CTBs results from the coordinated expression of gene products 
implicated during trophoblast invasion, such as integrins and MMPs, thus suggesting superior control by nuclear 
transcription factors. On the other hand, external stimuli induce intracellular signal transduction that could result 
in the modulation of expression and/or activity of transcription factors. 
Using a transgenic mouse model system carrying homozygous gene mutations, several master regulators of 
trophoblast differentiation have been described [98, 99]. These transcription factors include Hand1, Mash2, Id2, 
E-factor, I-mfa, GCM1 and Sta13. Descriptive studies have shown that several of these factors are also expressed 
in the human placenta, suggesting that the mechanisms controlling trophoblast differentiation could be similar in 
mice and men. A chapter in this book is dedicated to this topic. 
Several transcription factors have already been examined. For instance, the promoter site of MMP-1, MMP-3 
and MMP-9 is able to bind the AP-1 complex, a heterodimer of Jun and Fos, which is thought to be important 
during the mediation of signals that lead to increased MMP expression. Indeed, the AP-1 complex is implicated 
in the MMP-1 response to IL-1, TNF and TGF-β [34, 62] and in the MMP-3 regulation by PDGF and TGF-β 
[34, 62]. Both Fos and Jun are highly expressed in human trophoblast [100]. Moreover, the effects of EGF on 
trophoblast proliferation and differentiation depend on modulation of c-fos and c-jun expression [101]. Jun-B is 
essential for the establishment of vascular connections with the maternal circulation during mouse placentation 
[102]. 
The transcription factor c-myc activates telomerase by interaction with the hTERT (telomerase reverse 
transcriptase) promoter [103] and seems essential for progression of the cell cycle. The expression of c-myc 
correlates with early trophoblast proliferation [104]. Moreover, expression of c-myc colocalizes with expression 
of c-sis, which encodes for the β chain of PDGF, and is thought to participate in the control of proliferation of 
trophoblasts [105]. 
An important transcription factor for placentation is the HIF-1 protein complex [106, 107], which binds a short 
DNA motif located in the 5'-flanking regions of various hypoxia-induced genes [108]. HIF-1 binds DNA as a 
heterodimer composed of 2 subunits, the constitutively expressed HIF-1 β (aryl hydrocarbon receptor nuclear 
translocator, ARNT) and HIF-1 α, which is induced in hypoxic conditions and is quickly degraded by the 
proteasome under normoxic conditions through an interaction with the von Hippel-Lindau tumor suppressor 
protein (pVHL) [109]. Trophoblasts grown under hypoxic conditions are used to model the cellular environment 
of normal and preeclamptic gestation [110, 111]. Indeed, normoxic CTBs differentiate towards an invasive 
phenotype, which allows them to invade Matrigel [5, 41], as observed in invasive intermediate trophoblasts that 
are in a hypoxic environment. Hypoxic conditions (2% O2) induce trophoblast proliferation, increase fibronectin 
synthesis, expression of α5 integrin, gelatinase A activity, and inhibit invasion, due at least in part to their 
inability to switch their integrin repertoire, such as induction of α1β1 [70, 110]. This is thought to reflect the 
behavior of trophoblasts that have invaded the maternal bloodstream, are in contact with oxygenated blood and 
have decreased their invasive phenotype. These phenotypical changes could be related to the modulated 
expression of HIF-1. Indeed, expression of HIF-1α is high during the first trimester of gestation, decreases after 
9 weeks when placental pO2 levels are believed to increase, and is absent at 11-14 weeks and afterwards [70]. 
This observation fits with the hypothesis that the placental environment is hypoxic during the first trimester of 
gestation until invasive CTBs invade the uterine arteries [112-115]. The expression of pVHL, implicated in 
initiating the degradation of HIF-1α, is highly expressed at sites of column initiation and is increased by hypoxia 
[116]. 
CONCLUSIONS 
A large body of literature is now available to better explain the molecular mechanisms of trophoblastic invasion. 
However, important questions still remain unanswered, and need further investigation. Understanding 
trophoblast invasion could also provide insights into the pathogenesis of preeclampsia. These data could 
constitute the basis for new therapeutic strategies for this disease. 
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